Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
about
Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza InfectionMeasuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesRegulating the adaptive immune response to respiratory virus infectionDiscovery of a protective Rickettsia prowazekii antigen recognized by CD8+ T cells, RP884, using an in vivo screening platformDistinct APC subtypes drive spatially segregated CD4+ and CD8+ T-cell effector activity during skin infection with HSV-1Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumoniaThe kinematics of cytotoxic lymphocytes influence their ability to kill target cellsDiscs Large Homolog 1 Splice Variants Regulate p38-Dependent and -Independent Effector Functions in CD8+ T Cells.Alveolar Macrophages Prevent Lethal Influenza Pneumonia By Inhibiting Infection Of Type-1 Alveolar Epithelial CellsType I IFN signaling facilitates the development of IL-10-producing effector CD8+ T cells during murine influenza virus infection.IL-21R signaling suppresses IL-17+ gamma delta T cell responses and production of IL-17 related cytokines in the lung at steady state and after Influenza A virus infection.Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection.The effector T cell response to influenza infectionAerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.T cell responses during influenza infection: getting and keeping control.Viral infection of the lung: host response and sequelaeLate engagement of CD86 after influenza virus clearance promotes recovery in a FoxP3+ regulatory T cell dependent manner.Role of T cell immunity in recovery from influenza virus infectionGroup 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infectionRecent insights into pulmonary repair following virus-induced inflammation of the respiratory tract.Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cellsAutocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus.An evolving autoimmune microenvironment regulates the quality of effector T cell restimulation and functionSoluble, but not transmembrane, TNF-α is required during influenza infection to limit the magnitude of immune responses and the extent of immunopathologySuboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo.Prolonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells.Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma.Phenotype of the anti-Rickettsia CD8(+) T cell response suggests cellular correlates of protection for the assessment of novel antigens.Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection.A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection.Murine CD4+ T cell responses are inhibited by cytotoxic T cell-mediated killing of dendritic cells and are restored by antigen transfer.Influenza, immune system, and pregnancyLack of PD-L1 expression by iNKT cells improves the course of influenza A infection.Duration of antigen availability influences the expansion and memory differentiation of T cells.Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phaseDendritic cell function at the maternal-fetal interface.Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung InjuryChronic ethanol exposure selectively inhibits the influenza-specific CD8 T cell response during influenza a virus infection.A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus InfectionAerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses
P2860
Q26767517-DD6DD688-F607-4A85-889C-6AED90524FF3Q26783884-D5FFE549-BD00-4076-9CAE-84E70A300826Q27014696-14AC7B43-F7C1-4613-9F06-F7B622F3885CQ27304785-70AEB106-1FD1-4FCC-9F8E-C84483EAEAAAQ27324479-2102F58E-3964-49B4-BF61-F85991131FCEQ27336255-C593B001-0C39-4230-A356-78744E17092AQ27337590-F4B76C86-BE1E-4912-A164-2B07E36469AAQ30009140-F664709E-5F19-460D-B411-54D4BF6E1640Q30275003-8C8EAB17-A2E2-4893-B955-0C1E40330D12Q30275794-CF7A9062-0398-4025-9D34-52774A695D03Q30300227-650E2147-EF2A-4D3B-BFC4-AA5A195FD872Q30301182-8A4B59BB-E792-4997-89DE-A235C672F624Q30361773-D2AA3A69-2DAD-4D23-979B-35D27F3CB004Q30388110-3DC5CAF3-7EDD-4D76-B802-E70FD7AE975EQ30401137-EDABD518-FFE0-47A4-AFCE-7E13E4DC76F5Q30409296-40BF8D8B-6729-4DA3-B651-E7353AFF93C2Q30411194-CABCB81B-F607-457E-AF71-73B4F5724B1BQ30411514-10953A40-6DB8-4F3A-99D2-658AD803BB8EQ30417087-EC1F2974-D325-45C1-B39B-B63DDD9BC73FQ30419007-A6664096-1669-4FC3-87C4-BBC26A826FB6Q30424573-61F134BF-A795-494A-B816-5E6B00373545Q30431134-CC9F5E51-EC18-4804-B806-D4E20C45334BQ30582456-A88A0FB6-B3D4-48A0-95C0-A127C51FDD3EQ33723788-DB5ED220-BFAA-4BC4-8050-ED82FCF7F6B5Q33921252-C017A797-30B5-4DD4-95AB-02756D66185EQ33964275-15B9F76D-6812-4DAB-AC30-14887543017EQ34052565-1B1BA5DB-20AB-42DB-AA23-820A07FA8EC8Q34069134-94A7717C-D194-498F-9154-C7616A4F59F2Q34071375-E903A92D-DFDF-4F69-BA54-00BE574296A5Q34187000-5C336830-F96E-44C6-84AF-5CA4358DCE40Q34287488-9269FE5A-22C1-4EF2-A6BB-F317823E4BCAQ34506733-E85524FD-7BEA-44A8-8F32-F8732D8C818FQ34649276-E4BBCDF6-11A7-4708-973F-8047362B1C66Q35175877-7579EE95-01E5-49BB-8EA6-783EBDA7AEDAQ35407260-FBDD6B42-5C88-43D3-B8AE-B2F0CB23E547Q35551264-22268B70-1D08-4DF7-AA9F-F611BC834E76Q35666900-A97BBED3-64CC-4CB0-AE00-C1F8EFDD5D1FQ35707047-EA814400-9079-48BA-9BA1-C599DFFEB30AQ35905711-5D847791-E2E3-49DB-B109-8847A16A8FFFQ36040533-B9EEE5C7-AE59-467B-BBE7-0FFC8AC6026C
P2860
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
@ast
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
@en
type
label
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
@ast
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
@en
prefLabel
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
@ast
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
@en
P2093
P2860
P356
P1476
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type
@en
P2093
Matthew M Hufford
Taeg S Kim
P2860
P304
P356
10.1084/JEM.20101850
P407
P577
2010-12-27T00:00:00Z